National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data

Published:2023-12 Issue:12 Volume:8 Page:e943-e955
ISSN:2468-2667
Container-title:The Lancet Public Health
language:en
Short-container-title:The Lancet Public Health

Author:

Qi Jinlei,Li Menglong,Wang Lijun,Hu Yifei,Liu Wei,Long Zheng,Zhou Zifang,Yin Peng,Zhou Maigeng

Funder

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health

Reference29 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019;Kocarnik;JAMA Oncol,2022

3. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019;Lin;J Hematol Oncol,2021

4. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

5. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Zhou;Lancet,2019

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-cancer analysis of m1A writer gene RRP8: implications for immune infiltration and prognosis in human cancers;Discover Oncology;2024-09-12

2. CircBIRC6 affects prostate cancer progression by regulating miR-574-5p and DNAJB1;Cancer Biology & Therapy;2024-09-11

3. The short-term efficacy of neoadjuvant SOX versus SOX plus immune checkpoint inhibitor following laparoscopic gastrectomy for locally advanced gastric cancer: a multicenter retrospective cohort study in China;Cancer Immunology, Immunotherapy;2024-09-05

4. Self-Assembled Nanoparticles of Silicon (IV)–NO Donor Phthalocyanine Conjugate for Tumor Photodynamic Therapy in Red Light;Pharmaceutics;2024-09-04

5. Targeting TNFR2 for cancer immunotherapy: recent advances and future directions;Journal of Translational Medicine;2024-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3